Diminazene aceturate belongs to the group of aromatic diamidines with therapeutic activity against babesiosis, piroplasmosis and trypanosomiasis.
Treatment of babesiosis, piroplasmosis and trypanosomiasis in camels, horses, cattle, swine, sheep, goats, dogs and cats.
Administration to animals with known hypersensitivity to diminazene and/or phenazone.
Administration to animals with an impaired renal and/or hepatic function.
Hypersensitivity reactions have been reported. Salivation, sweating, tremors can occur.
Multiple therapeutic doses can produce severe nervous signs and prominent haemorrhagic and malacic lesions of the cerebellum, midbrain, and thalamus in dogs.
After multiple therapeutic doses degenerative fatty changes can occur in liver, kidneys, myocardium and muscles.
Multiple therapeutic doses can produce prominent haemorrhagic and malacic lesions of the cerebellum and the thalamus in cattle.
For deep intramuscular administration.
General: Dissolve 2.36 g (23.6 g) of powder in 15 ml (150 ml) of sterile water before use to prepare a solution for injection, and administer at 1 ml per 20 kg body weight (i.e. 2.36 g (23.6 g) per 300 kg (3000 kg) body weight). Use only freshly prepared solutions for injections.
- For meat: 21 days.
- For milk: 4 days.